Guidelines of German urologists on diagnosis of benign prostate syndrome;Leitlinien der Deutschen urologen zur diagnostik des benignen prostatasyndroms (BPS)

Urologe - Ausgabe A

Volumn 42, Issue 4, 2003, Pages 584-590

  Palmtag, H ^a   Goepel, M ^a   Berges, R ^a   Dreikorn, K ^a   Hofner K ^a   Jonas, U ^a   Laval, K U ^a   Madersbacher, S ^a   Michel, M C ^a   Muschter, R ^a   Oelke, M ^a   Pientka, L ^a   Tschuschke, C ^a   Tunn, U ^a   Schalkhauser K ^a   Gockel Beining B ^a   Heidenreich, A ^a   Rubben H ^a   Thon, W ^a   Thuroff J ^a   Weidner, W ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ECHOGRAPHY; GERMANY; HUMAN; INCIDENCE; LABORATORY TEST; NOMENCLATURE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PROSTATISM; REVIEW; SYMPTOMATOLOGY; UROFLOWMETRY; UROLOGY;

EID: 0037599607     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0319-2     Document Type: Review

References (75)

1. Aarnink RG, de la Rosette JJ, Debruyne FM, Wijkstra H (1996) Formula-derived prostate volume determination. Eur Urol 29: 399-402
2. Aarnink RG, de la Rosette JJ, Debruyne FM, Wijkstra H (1996) Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. B J Urol 78: 219-223
3. Abrams P (1995) Objective evaluation of bladder outlet obstruction. Br J Urol 76: 11-15
4. Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T (1994) The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy. J Urol 152: 443-447
5. Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E (1995) Age-specific reference ranges for serum prostate-specific antigen. Urology 46: 54-57
6. Anyanwu SNC (1995) Is routine urography necessary in all patients undergoing suprapubic transvesical prostatectomy? East Afr Med J 72/2: 78
7. Barry MJ, Cockett AT, Holtgrewe HL et al. (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150: 351-358
8. Bergdahl S, Aus G, Lodding P, Norlen L, Hugosson J (1999) Transrectal ultrasound with separate measurement of the transition zone predicts the short-term outcome after transurethral resection of the prostate. Urology 53: 926-930
9. Bosch JL (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13: 17-20
10. Bosch JL, Hop WC, Kirkels WJ, Schröder FH (1995) The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75: 622-630
11. Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoided residual urine determination in evaluation of prostatism. Urology 20: 602-604
12. Chandiramani VA, Palace J, Fowler CJ (1997) How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 80: 100-104
13. Chapple CR, Smith D (1994) The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 73: 117-121
14. Comiter CV, Sullivan MP, Schacterle RS, Cohen LH, Valla SV (1997) Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. J Urol 158: 181-185
15. De la Rosette JJ, Witjes WP, Debruyne FM, Kerstein PL, Wijkstra H (1996) Improved reliability of uroflowmetry investigations: results of a portable home-based uroflowmetry study. Br J Urol 78: 385-390
16. Diokno AC (1996) Editorial: the impact of technological and scientific advances in understanding, evaluating and managing bladder and outlet obstruction. J Urol 155: 527-158
17. Dörsam J, Kälble T, Riedasch G, Staehler G (1994) Wertigkeit der bildgebenden Diagnostik bei benigner Prostatahyperplasie und beim Prostatakarzinom. Radiologe 34: 101-108
18. DuBeau CE, Sullivan MP, Cravalho E, Resnick NM, Yalla SV (1995) Correlation between micturitional urethral pressure profile and pressure-flow criteria in bladder outlet obstruction. J Urol 154: 498-503
19. Dunsmuir WD, Feneley M, Corry DA, Bryan CJ, Kirby RS (1996) The day-to-day variation (test-retest reliability) of residual urine measurement. Br J Urol 77 2: 192-193
20. El Din K, Koch WF, de Wildt MJ, Debruyne FM, de la Rosette JJ (1996) The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol 30: 409-413
21. El Din KE, Kiemeney LA, de Wildt MJ, Debruyne FM, de La Rosette JJ (1996) Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score. Urology 48: 393-397
22. Fall M, Geirsson G, Lindstrom S (1995) Towards a new classification of overactive bladders. Neurourol Urodyn 14/6: 635-646
23. Feneley MR, Dunsmuir WD, Pearce J, Kirby RS (1996) Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology 47/5: 658-663
24. Gerber GS (1996) The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 48: 668-675
25. Gleason DM, Bottaccini MR, McRae LP (1997) Noninvasive urodynamics: a study of male voiding dysfunction. Neurourol Urodyn 16: 93-100
26. Goessl C, Knispel HH, Miller K, Klan R (1997) Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol 157: 480-481
27. Goldenberg S, Gleave M, Bruchovsky N, Rennie P (1997) The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the forthe diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis - Editorial Comment. J Urol 157: 2267
28. Griffiths D (1995) Basics of pressure-flow studies. World J Urol 13: 30-33
29. Griffiths D, Harrison G, Moore K, McCracken P (1994) Long-term changes in urodynamics studies of voiding in the elderly. Urol Res 22: 235-238
30. Griffiths K, Coffey D, Cockett A et al. (1996) The regulation of prostatic growth. In: Cockett ATK, Khoury S, Aso Y et al. (eds) The 3rd International Consultation on Benign Prostatic Hyerplasia (BPH). Scientific Communication International, Monaco, pp 73-121
31. Griffiths D, Höfner K, van Mastrigt R et al. (1997) Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn 16: 1-18
32. Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49: 749-754
33. Hall MC, Roehrborn CG, McConnell JD (1996) Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia? Seminars in Urologic Oncology 14: 122-133
34. Hampson SJ, Noble JG, Richards D, Milroy EJG (1992) Does residual urine predispose to urinary tract infection? Br J Urol 70: 506-508
35. Harzmann R, Weckermann D (1995) Diagnostikund Therapie des Prostataadenoms - Bewährtes und Neues. Med Welt 46: 454-457
36. Hasegawa Y, Yakamoto N, Gotoh K (1996) Relationship of ultrasonic and histologic findings in benign prostatic hyperplasia. Prostate 28/2: 111-116
37. Höfner K, Kramer EJ, Tan HK, Krah H, Jonas U (1995) CHE55 classification of bladder-outflow obstruction. A consequence in the discussion of current concepts. World Journal of Urology 13: 59-64
38. Jacobsen SJ (1995) Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology 45: 64-69
39. Janknegt RA, Roehrborn CG (1994) The role of the general practitioner in the diagnosis and treatment of benign prostatic hyperplasia (BPH). Prog Clin Biol Res 386: 313-329
40. Javle P, Jenkins SA, West C, Parsons KE (1996) Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy. J Urol 156: 1014-1019
41. Jensen KM, Jorgensen JB, Morgensen P (1996) Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms. Br J Urol 78/27: 213-218
42. Jonas U, Kramer G, Hofner K (1994) The principles and clinical application of advanced urodynamic analysis for BPH. Prog Clin Biol Res 386: 141-156
43. Jonas U, Höfner K (1996) Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia - Editorial. J Urol 156: 1040-1041
44. Jorgensen JB, Jensen KM (1996) Uroflowmetry. Urol Clin North Am 23/2: 237-242
45. Kaplan SA, Te AE (1995) Uroflowmetry and urodynamics. Urol Clin North Am 22: 309-320
46. Kaplan SA, Reis RB (1996) Significant correlation of the American Urological Association symptom score and a novel urodynamic parameter: Detrusor contraction duration. J Urol 156: 1668-1672
47. Koch WF, Ezzeldin K, de Wildt MJ, Debruyne FM, de la Rosette JJ (1996) The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 155: 186-189
48. Kojima M, Inui E, Ochiai A et al. (1997) Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol 157: 476-479
49. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K (1998) Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 51: 595-600
50. Lim CS, Abrams P (1995) The Abrams-Griffiths Nomogram. World J Urol 13: 34-39
51. Madersbacher S, Klingler HC, Diavan B et al. (1997) Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? Br J Urol 80: 72-77
52. Madsen FA, Bruskewitz RC (1995) Cystoscopy in the evaluation of benign prostatic hyperplasia. World J Urol 13: 14-16
53. Manieri C, Carter SS, Romano G et al. (1998) The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 159: 761-765
54. McConnell JD (1994) Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology 44: 156-158
55. McGuire E (1996) Editorial comment - Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourol Urodyn 15: 470-471
56. Nathan MS, Seenivasagam K, Mei Q, Wickham JE, Miller RA (1996) Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate? Br J Urol 77: 401-407
57. Netto NR, D'Ancona CAL, Lopes de Lima M (1996) Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia. J Urol 155: 200-202
58. Oelke M, Höfner K, Jonas U (2000) Standardisierung der sonographischen Detrusordickenmessung. Urologe A 39 (Suppl. 1): 136
59. Oelke M, Höfner K, Wiese B, Grünewald V, Jonas U (2002) Increase in detrusor wall thickness indicates bladder outlet obstruction (B00) in men. World J Urol 19: 443-452
60. Oesterling JE, Girman CJ, Panser LA et al. (1994) Correlation between urinary flow rate, voided volume, and patient age in a community-based population. Prog Clin Biol Res 386: 12S-139
61. Othani T, Hayashi Y, Kishino TE et al. (1999) A new parameter in decision making for transurethral electroresection of benign prostatic hyperplasia. Eur Urol 35: 185-191
62. Reynard JM, Peters TJ, Lim C, Abrams P (1996) The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol 77: 813-818
63. Reynard JM, Yang Q, Donovan JL et al. (1998) The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 82: 619-623
64. Roehrborn CG, Girman CJ, Rhodes T et al. (1997) Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 49: 548-557
65. Rosier PF, de la Rosette JJ (1995) Is there a correlation between prostata size and bladder-outlet obstruction? World J Urol 13: 9-13
66. Ruud Bosch JL (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13: 17-20
67. Schacterle RS, Sullivan MP, Yalla SV (1996) Reply - Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourol Urodyn 15: 471-472
68. Schäfer W, de la Rosette JJ, Höfner K et al. (1994) The ICS BPH study: pressure-flow studies, quality control and initial analysis. Neurourol Urodyn 13: 491-492
69. Schleicher C, Neumann R, Kaiser WA, Stein G (1997) Zur Indikation der intravenösen Urographie. Med Klin 92: 79-82
70. Sullivan MP, Comiter CV, Yalla SV (1996) Micturitional urethral pressure profilometry. Urol Clin North Am 23/2: 263-278
71. Ukimura O, Kojima M, Inui E et al. (1996) A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography. J Urol 156: 1673-1678
72. van de Beek C, Stoevelaar HJ, McDonnell J et al. (1997) Interpretation of uroflowmetry curves by urologists. J Urol 157: 164-168
73. van Venrooij GE, Boon TA (1996) The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis. J Urol 155/6: 2014-2018
74. Walsh PC (1984) Human benign prostatic hyperplasia: etiological considerations. In: Kimball FA et al. (eds) New approaches to the study of benign prostatic hyperplasia. Alan R Liss, New York, pp 1-25
75. Witjes WP, de Wildt MJ, Rosier PF et al. (1996) Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. J Urol 156: 1026-1033